BGF World Healthscience vs UBS Lux Equity Fund Biotech USD

BGF World Healthscience vs UBS Lux Equity Fund Biotech USD

1. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

Fund Holdings

We have information about 20 holdings in BGF World Healthscience, where the largest holding is UnitedHealth (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67). In comparison with UBS Lux Equity Fund Biotech USD, we have 7 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66).

All Holdings

Here we compare the holdings in BGF World Healthscience and UBS Lux Equity Fund Biotech USD.

BGF World Healthscience UBS Lux Equity Fund Biotech USD
1. UnitedHealth Group Inc
USA
8.2 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Eli Lilly and Co
USA
7.01 %
2. Moderna Inc
9.21 %
3. Novo Nordisk B
Denmark
6.67 %
3. Gilead Sciences Inc
USA
4.66 %
4. Merck & Co Inc
Germany
3.99 %
4. BioNTech SE
4.13 %
5. Boston Scientific Corp
3.67 %
5. Karuna Therapeutics Inc
3.75 %
6. AbbVie Inc
USA
3.61 %
-
7. Amgen Inc
USA
3.58 %
-
8. Sanofi SA
France
3.05 %
-
9. Abbott Laboratories
USA
3.02 %
-
10. AstraZeneca
Sweden UK
2.98 %
-

The list of fund holdings was last updated on September 10, 2025.